ReConnex is a ready-to-use, FDA 510(k)-cleared device designed to help simplify all-inside anterior cruciate ligament reconstruction.
Miach Orthopaedics initiated the Bridge Registry to assess real-world outcomes for the Bridge-Enhanced ACL Restoration (BEAR) Implant.
Sourced from bovine achilles tendon, the Type 1 collagen used in the wound dressing leverages robust biological properties that support tissue regeneration and repair.
ReConnex is a ready-to-use, FDA 510(k)-cleared device designed to help simplify all-inside anterior cruciate ligament reconstruction.
Miach Orthopaedics initiated the Bridge Registry to assess real-world outcomes for the Bridge-Enhanced ACL Restoration (BEAR) Implant.
Sourced from bovine achilles tendon, the Type 1 collagen used in the wound dressing leverages robust biological properties that support tissue regeneration and repair.
Newton converts soft tissue dynamics into actionable intraoperative guidance, supporting more consistent and reproducible surgical execution.
The U.S. Phase III trial expands the investigation of umbilical cord therapy for symptomatic cartilage defects due to knee OA.
The platform is designed to address the operational barriers that may limit minimally invasive spine surgery.
The implant is a knitted surgical scaffold in the form of a band intended to provide fixation during the healing process following syndesmotic trauma.
The naturally-derived hyaluronic acid and alginate hydrogel is designed to provide a conformable, bioresorbable gliding interface.
Lantern ASC includes a reusable navigation unit paired with a procedural Smart Pack Kit to integrate into existing surgical workflows.
NanoCept coating technology is intended to mitigate bacterial contamination on the implant surface prior to implantation.
The Saber-C system combines the stability of traditional anterior cervical plating with a zero-profile interbody construct.
VersaLift offers one of the smallest starting heights available for a TLIF expandable interbody implant, beginning at just 6mm.
MISHA is shown to be effective for knee OA patients who failed non-surgical treatments, but are not indicated or are unwilling to get a knee replacement.
The project is on track to reach the next milestone toward CE Mark approval of HyProtect-coated revision implants.
FDA approved an IDE application for a pivotal clinical trial of SOLA-2 Alternating Magnetic Field System in patients with periprosthetic joint infections.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.
